Tachifludec 16 Envelopes Lemon Honey,Tachifludec 16 Buste Limone Miele,ANGELINI SPA

“INDICATIONS: symptomatic treatment of influenza, colds and febrile conditions and pain associated with them, with a decongestant effect on the first upper respiratory tract.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to components or other substances that closely corr elate from a chemical point of view. Patients taking beta-blockers, monoaminoossidasi inhibitors and tricyclic antidepressants. Patients, nti, suffering from liver or kidney failure, diabetes mellitus, hyperthyroidism, arterial hypertension and cardiovascular diseases. Products based on paracine tamara are contraindicated in patients with de lla glucose-6-phosphate dehydrogenase deficiency and in those who suffer from severe anemia and. A. hemolytic. Severe hepatocellular failure.
DOSAGE: Adults and children over 12 years of age: 1 sachet every 4-6 hours up to or no more than 3 sachets in 24 hours. Dissolve 1 sachet in a glass of very hot water and, to taste, dilute with cold water to cool and sweeten as you wish. The product should not be prescribed to children under 12 years of age unless under the direction of a physician.
Special INSTRUCTIONS: During treatment with paracetamol, before taking any other drug, check that it does not contain the same active ingredient, because if is taken in high doses, serious adverse reactions may occur. Instruct patient to contact med ico before combining any other medication. The use of d el product is not recommended if the patient is taking anti-inflammatory drugs. – Due to the presence of sodium, the product should be used with caution in those on a low-sodium diet. – Due to the presence of sugars sio (3725 mg per sachet in TACHIFLUDEC packaging lemon flavor and 3802 mg per sachet in TACHIFLUDEC packaging honey-lemon flavor), and the production of eight should be used with caution in patients with intolerance to fructose, glucose malabsorption syndrome -galactose or in case of deficiency due to sucrase-isomaltase. Keep the medicinal product out of the reach of children.
INTERACTIONS: The hepatotoxic effect of may be increased by other active drugs on the liver. Use with extreme caution and under strict supervision during treatment of chronic medications that may induce hepatic monossigenasis or in case of exposure to substances that may have such an effect (for example, rifampicin, cimetidine, antiepileptics such as glutetimmide, fenob arbital, carbamazepine). Taking can inte rferire with the determination of uricemia (acid, phosphorus method) and blood sugar levels (glucose oxidase-peroxidase method). increases the half-life of chloramphenicol. The product in high doses may enhance the air anticoagulant effect of coumarin. Phenylephrine can antagonize the effect of beta-blockers and antihypertensive drugs and p u’ potentiate the effect of inhibitors of monoaminoossidasi.
SIDE EFFECTS: Skin reactions of varying type and severity have been reported with the use of paracetamol, including cases of erythema multiforme, Stevens Johnson syndrome and epidermal necrolysis. Sensitivity reactions, such as angioedema, laryngeal edema, and anaphylactic shock, have been reported. In addition, the following effects were recorded: thrombocytopenia, leukopenia, anemia, agranulocytosis, changes in liver function and hepatitis, changes in the load on the kidneys (acute renal failure, interstitial nephritis, hematuria, anuria), gastrointestinal reactions and dizziness . With sympathomimetics (phenylephrine), skin irritation, tachycardia, hypertension, and much less commonly nausea, vomiting or anorexia may sometimes occur.
PREGNANCY AND LACTATION: use during pregnancy is not contraindicated, but requires caution; taking the drug during pregnancy and lactation should occur under the direct supervision of a physician and in case of actual tive need.”